WS #13332

16:52→17:22 UTC
From 500 msgs · 6 key-dev

Investors reject $400B AstraZeneca-Bristol Myers merger, with AZN down 8% and BMY down, signaling deal skepticism.

AZN-BMY merger rejection

Investors reject $400B AstraZeneca-Bristol Myers merger, with AZN down 8% and BMY down, signaling deal skepticism.

Full world state #13332 →

US-Iran de-escalation fragilityAmazon $3T milestoneISM manufacturing strength with inflation
← WS #13331WS #13333 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|